Literature DB >> 16080418

Quality of care measures for the treatment of bipolar disorder.

Farifteh Firoozmand Duffy1, William Narrow, Joyce C West, Laura J Fochtmann, David A Kahn, Trisha Suppes, John M Oldham, John S McIntyre, Ronald W Manderscheid, Paul Sirovatka, Darrel Regier.   

Abstract

The staff of the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and a national panel of experts in bipolar disorder and practice guideline development have collaborated to generate a set of quality of care indicators for the pharmacologic and psychosocial treatment of bipolar disorder. The indicators were derived from APA's evidence-based Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2002 (1) and the Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder, 2000 (2) These quality indicators can be used for quality monitoring, benchmarking, and quality improvement efforts across health plans, systems of care, and health care providers to improve quality and outcomes of care for patients with bipolar disorder.

Entities:  

Mesh:

Year:  2005        PMID: 16080418     DOI: 10.1007/s11126-005-2975-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  35 in total

Review 1.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

Review 2.  Aligning incentives in the treatment of depression in primary care with evidence-based practice.

Authors:  Richard G Frank; Haiden A Huskamp; Harold Alan Pincus
Journal:  Psychiatr Serv       Date:  2003-05       Impact factor: 3.084

3.  The philosophical limits of evidence-based medicine.

Authors:  M R Tonelli
Journal:  Acad Med       Date:  1998-12       Impact factor: 6.893

Review 4.  Is health care ready for Six Sigma quality?

Authors:  M R Chassin
Journal:  Milbank Q       Date:  1998       Impact factor: 4.911

Review 5.  Evidence-based practice guidelines.

Authors:  D A Zarin; L Seigle; H A Pincus; J S McIntyre
Journal:  Psychopharmacol Bull       Date:  1997

6.  The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

Authors:  C E Begley; J F Annegers; A C Swann; C Lewis; S Coan; W B Schnapp; L Bryant-Comstock
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 7.  Does ECT alter brain structure?

Authors:  D P Devanand; A J Dwork; E R Hutchinson; T G Bolwig; H A Sackeim
Journal:  Am J Psychiatry       Date:  1994-07       Impact factor: 18.112

8.  The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

Authors:  D A Regier; W E Narrow; D S Rae; R W Manderscheid; B Z Locke; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1993-02

9.  An economic evaluation of manic-depressive illness--1991.

Authors:  R J Wyatt; I Henter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-08       Impact factor: 4.328

10.  Overview, History, and Objectives of Performance Measurement.

Authors:  Dennis McIntyre; Lisa Rogers; Ellen Jo Heier
Journal:  Health Care Financ Rev       Date:  2001
View more
  5 in total

1.  Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement.

Authors:  Amy M Kilbourne; Carrie Farmer Teh; Deborah Welsh; Harold Alan Pincus; Elaine Lasky; Brian Perron; Mark S Bauer
Journal:  Gen Hosp Psychiatry       Date:  2010-10-30       Impact factor: 3.238

Review 2.  Reporting standards for guideline-based performance measures.

Authors:  Monika Nothacker; Tim Stokes; Beth Shaw; Patrice Lindsay; Raija Sipilä; Markus Follmann; Ina Kopp
Journal:  Implement Sci       Date:  2016-01-15       Impact factor: 7.327

3.  Pharmacologic management of bipolar disorder in a Medicare Advantage population.

Authors:  Hsiang Huang; Jessica L Gören; Ya-Fen Chan; Wayne Katon; Joan Russo; Diane Hogan; Jürgen Unützer
Journal:  Psychosomatics       Date:  2014-04-19       Impact factor: 2.386

Review 4.  Methods for the guideline-based development of quality indicators--a systematic review.

Authors:  Thomas Kötter; Eva Blozik; Martin Scherer
Journal:  Implement Sci       Date:  2012-03-21       Impact factor: 7.327

5.  Approaches of integrating the development of guidelines and quality indicators: a systematic review.

Authors:  Miranda W Langendam; Thomas Piggott; Monika Nothacker; Arnav Agarwal; David Armstrong; Tejan Baldeh; Jeffrey Braithwaite; Carolina Castro Martins; Andrea Darzi; Itziar Etxeandia; Ivan Florez; Jan Hoving; Samer G Karam; Thomas Kötter; Joerg J Meerpohl; Reem A Mustafa; Giovanna E U Muti-Schünemann; Philip J van der Wees; Markus Follmann; Holger J Schünemann
Journal:  BMC Health Serv Res       Date:  2020-09-16       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.